{"nctId":"NCT04756804","briefTitle":"Perioperative Patient Skin Antiseptic Preparation Evaluation","startDateStruct":{"date":"2021-06-21","type":"ACTUAL"},"conditions":["Surgical Site Infection"],"count":51,"armGroups":[{"label":"70% Isopropyl Alcohol novel preoperative skin antiseptic","type":"EXPERIMENTAL","interventionNames":["Drug: 70% v/v Isopropyl Alcohol Surgical Solution"]},{"label":"2% Chlorhexidine Gluconate/70% Isopropyl Alcohol preoperative skin antiseptic","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol"]}],"interventions":[{"name":"70% v/v Isopropyl Alcohol Surgical Solution","otherNames":["ZuraGard"]},{"name":"2%w/v Chlorhexidine Gluconate / 70% v/v Isopropyl Alcohol","otherNames":["ChloraPrep"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Be male or female and at least 18 years of age.\n2. Be able to verbalize an understanding of the consent form, able to provide written informed consent, verbalize willingness to complete study procedures, able to understand written and oral instructions in English.\n3. Be planning to undergo clean (class I wound) or clean-contaminated (class II wounds) surgery.\n4. Expect to be available for up to 30-days after the surgery.\n\nExclusion Criteria:\n\n1. Active infection or fever including evidence of infection at or adjacent to the operative site.\n2. Immunosuppressed.\n3. Kidney/liver failure.\n4. Immunosuppressive therapy (chemotherapy, steroids) within the previous 1 week.\n5. Any history of allergy to chlorhexidine or isopropyl alcohol or any other component in ZuraGard including citric acid, sodium citrate, methylparaben, or propylparaben, and FD\\&C Yellow #6.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Surgical Site Infection Occurrence","description":"The primary objective is to demonstrate efficacy in surgical use through the rate of surgical site infections.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"PRIMARY","title":"Allergic Reaction and Skin Irritation","description":"The primary safety objective is to determine the rates of skin irritation or allergic reactions attributed to each drug product and all other adverse events.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Subgroup Analysis of Rates of Surgical Site Infections","description":"Surgical site infection rates by different infection types classified as superficial incisional infection, deep incisional infection, or organ-space infection.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]},{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Subgroup Analysis of Rates of Surgical Site Infections","description":"Surgical site infection rates by type of surgery including clean (class I wound) or clean-contaminated (class II wounds) surgeries","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]},{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":25},"commonTop":[]}}}